首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: A new model of experimental scleroderma?
【24h】

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: A new model of experimental scleroderma?

机译:尿激酶型纤溶酶原激活剂受体(uPAR)基因的失活诱导小鼠皮肤和肺纤维化以及外周微血管病变:实验性硬皮病的新模型?

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Urokinase-type plasminogen activator receptor (uPAR) is a key component of the fibrinolytic system involved in extracellular matrix remodelling and angiogenesis. The cleavage/inactivation of uPAR is a crucial step in fibroblast-to-myofibroblast transition and has been implicated in systemic sclerosis (SSc) microvasculopathy. In the present study, we investigated whether uPAR gene inactivation in mice could result in tissue fibrosis and peripheral microvasculopathy resembling human SSc. Methods: The expression of the native full-length form of uPAR in human skin biopsies was determined by immunohistochemistry. Skin and lung sections from uPAR-deficient (uPAR-/-) and wild-type (uPAR+/+) mice at 12 and 24 weeks of age were stained with haematoxylin-eosin, Masson 's trichrome and Picrosirius red. Dermal thickness and hydroxyproline content in skin and lungs were quantified. Dermal myofibroblast and microvessel counts were determined by immunohistochemistry for α-smooth muscle actin and CD31, respectively. Endothelial cell apoptosis was assessed by TUNEL/CD31 immunofluorescence assay. Results: Full-length uPAR expression was significantly downregulated in SSc dermis, especially in fibroblasts and endothelial cells. Dermal thickness, collagen content and myofibroblast counts were significantly greater in uPAR-/- than in uPAR+/+ mice. In uPAR-/- mice, dermal fibrosis was paralleled by endothelial cell apoptosis and severe loss of microvessels. Lungs from uPAR-/- mice displayed non-specific interstitial pneumonia-like pathological features, both with inflammation and collagen deposition. Pulmonary pathology worsened significantly from 12 to 24 weeks, as shown by a significant increase in alveolar septal width and collagen content. Conclusions: uPAR-/- mice are a new animal model closely mimicking the histopathological features of SSc. This model warrants future studies.
机译:目的:尿激酶型纤溶酶原激活剂受体(uPAR)是纤溶系统中涉及细胞外基质重塑和血管生成的关键成分。 uPAR的裂解/失活是成纤维细胞向成肌纤维细胞转化的关键步骤,并且与系统性硬化症(SSc)微血管病有关。在本研究中,我们调查了小鼠中的uPAR基因失活是否会导致类似于人SSc的组织纤维化和外周微血管病变。方法:采用免疫组织化学方法检测人皮肤活检组织中uPAR的天然全长表达。用苏木精-伊红,马尾三色和Picrosirius红对12周和24周龄uPAR缺陷(uPAR-/-)和野生型(uPAR + / +)小鼠的皮肤和肺部进行染色。定量皮肤和肺中的皮肤厚度和羟脯氨酸含量。通过免疫组织化学分别测定α-平滑肌肌动蛋白和CD31的皮肤成肌纤维细胞和微血管计数。通过TUNEL / CD31免疫荧光测定法评估内皮细胞凋亡。结果:全长uPAR表达在SSc真皮中显着下调,尤其是在成纤维细胞和内皮细胞中。 uPAR-/-中的皮肤厚度,胶原蛋白含量和成肌纤维细胞计数明显高于uPAR + / +小鼠。在uPAR-/-小鼠中,真皮纤维化与内皮细胞凋亡和微血管严重丧失并行。来自uPAR-/-小鼠的肺表现出非特异性的间质性肺炎样病理特征,同时具有炎症和胶原蛋白沉积。从肺泡间隔宽度和胶原蛋白含量显着增加可以看出,肺部病理从12周到24周显着恶化。结论:uPAR-/-小鼠是一种新的动物模型,非常类似于SSc的组织病理学特征。该模型值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号